Literature DB >> 15472644

Cardiac neurotransmission SPECT imaging.

Albert Flotats1, Ignasi Carrió.   

Abstract

The sympathetic nervous system has great influence on cardiovascular physiology. Cardiac neurotransmission single photon emission computed tomography (SPECT) imaging allows in vivo noninvasive assessment of presynaptic reuptake and storage of neurotransmitters, which offers characterization of the cardiac neuronal function in different diseases of the heart and other altered metabolic or functional conditions. Therefore assessment of the integrity of cardiac sympathetic innervation may help in the diagnosis of these disorders, as well as in prognostication, and will result in better therapy and outcome. At present, the most widely available SPECT tracer by which to assess cardiac neurotransmission is metaiodobenzylguanidine labeled with iodine 123. This article focuses on reviewing the characteristics of cardiac SPECT imaging with I-123 metaiodobenzylguanidine and its role in the assessment of pathophysiologic changes during relevant clinical conditions.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15472644     DOI： 10.1016/j.nuclcard.2004.07.007

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  104 in total

1.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

2.  Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.

Authors:  C Zhao; N Shuke; W Yamamoto; A Okizaki; J Sato; Y Ishikawa; T Ohta; N Hasebe; K Kikuchi; T Aburano
Journal:  J Nucl Med       Date:  2001-07       Impact factor: 10.057

3.  Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.

Authors:  P Merlet; C Benvenuti; D Moyse; F Pouillart; J L Dubois-Randé; A M Duval; D Loisance; A Castaigne; A Syrota
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

4.  I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator.

Authors:  Rishi Arora; Kevin J Ferrick; Tomoaki Nakata; Robert C Kaplan; Michael Rozengarten; Farhana Latif; Kaman Ng; Vanessa Marcano; Sherman Heller; John D Fisher; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 5.  The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.

Authors:  S Braune
Journal:  Clin Auton Res       Date:  2001-12       Impact factor: 4.435

6.  Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis.

Authors:  A Cohen-Solal; Y Esanu; D Logeart; F Pessione; C Dubois; G Dreyfus; R Gourgon; P Merlet
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

7.  Myocardial imaging with a radioiodinated norepinephrine storage analog.

Authors:  D M Wieland; L E Brown; W L Rogers; K C Worthington; J L Wu; N H Clinthorne; C A Otto; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-01       Impact factor: 10.057

8.  Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy.

Authors:  J S Gill; G J Hunter; G Gane; A J Camm
Journal:  Am Heart J       Date:  1993-08       Impact factor: 4.749

9.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

Authors:  C Basso; G Thiene; D Corrado; A Angelini; A Nava; M Valente
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

10.  Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction.

Authors:  A I McGhie; J R Corbett; M S Akers; P Kulkarni; M N Sills; M Kremers; L M Buja; M Durant-Reville; R W Parkey; J T Willerson
Journal:  Am J Cardiol       Date:  1991-02-01       Impact factor: 2.778
View more
  27 in total

1.  Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions.

Authors:  Berlinda J van der Veen; Imad Al Younis; Albert de Roos; Marcel P M Stokkel
Journal:  J Nucl Cardiol       Date:  2012-06-06       Impact factor: 5.952

Review 2.  Radionuclide imaging of cardiac autonomic innervation.

Authors:  Sang Yong Ji; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 3.  Understanding the genetics of coronary artery disease through the lens of noninvasive imaging.

Authors:  Eunice Yang; Jose D Vargas; David A Bluemke
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-01

Review 4.  Myocardial perfusion scintigraphy: past, present and future.

Authors:  A Notghi; C S Low
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

5.  Quantitation of cardiac sympathetic innervation in rabbits using 11C-hydroxyephedrine PET: relation to 123I-MIBG uptake.

Authors:  Yusuke Nomura; Ichiro Matsunari; Hiroyuki Takamatsu; Yoshihiro Murakami; Takahiro Matsuya; Junichi Taki; Kenichi Nakajima; Stephan G Nekolla; Wei-Ping Chen; Kouji Kajinami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-24       Impact factor: 9.236

Review 6.  Radionuclide noninvasive evaluation of heart failure beyond left ventricular function assessment.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2009-02-27       Impact factor: 5.952

7.  Role of cardiac nuclear imaging in the management of critically ill patients.

Authors:  Alia Fattah
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09       Impact factor: 9.236

Review 8.  Current Clinical Applications and Next Steps for Cardiac Innervation Imaging.

Authors:  Mark I Travin
Journal:  Curr Cardiol Rep       Date:  2017-01       Impact factor: 2.931

Review 9.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

Review 10.  New horizons in cardiac innervation imaging: introduction of novel 18F-labeled PET tracers.

Authors:  Ryohei Kobayashi; Xinyu Chen; Rudolf A Werner; Constantin Lapa; Mehrbod S Javadi; Takahiro Higuchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-13       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.